Characterizing Long COVID in Children and Adolescents.

Creator(s)

Rachel S. Gross
Tanayott Thaweethai
Lawrence C. Kleinman
Jessica N. Snowden
Erika B. Rosenzweig
Joshua D. Milner
Kelan G. Tantisira
Kyung E. Rhee
Terry L. Jernigan
Patricia A. Kinser
Amy L. Salisbury
David Warburton
Sindhu Mohandas
John C. Wood
Jane W. Newburger
Dongngan T. Truong
Valerie J. Flaherman
Torri D. Metz
Elizabeth W. Karlson
Lori B. Chibnik
Deepti B. Pant
Aparna Krishnamoorthy
Richard Gallagher
Michelle F. Lamendola-Essel
Denise C. Hasson
Stuart D. Katz
Shonna Yin
Benard P. Dreyer
Megan Carmilani
K Coombs
Megan L. Fitzgerald
Nick Güthe
Mady Hornig
Rebecca J. Letts
Aimee K. Peddie
Brittany D. Taylor
RECOVER-Pediatrics Consortium
RECOVER-Pediatrics Group Authors
Venkataraman Balaraman
Amanda Bogie
Hulya Bukulmez
Allen J. Dozor
Daniel Eckrich
Amy J. Elliott
Danielle N. Evans
Jonathan S. Farkas
E Vincent S. Faustino
Laura Fischer
Sunanda Gaur
Ashraf S. Harahsheh
Uzma N. Hasan
Daniel S. Hsia
Gredia Huerta-Montañez
Kathy D. Hummel
Matt P. Kadish
David C. Kaelber
Sankaran Krishnan
Jessica S. Kosut
Jerry Larrabee
Peter Paul C. Lim
Ian C. Michelow
Carlos R. Oliveira
Hengameh Raissy
Zaira Rosario-Pabon
Judith L. Ross
Alice I. Sato
Michelle D. Stevenson
Maria M. Talavera-Barber
Ronald J. Teufel
Kathryn E. Weakley
Emily Zimmerman
Marie-Abele C. Bind
James Chan
Zoe Guan
Richard E. Morse
Harrison T. Reeder
Natascha Akshoomoff
Judy L. Aschner
Rakesh Bhattacharjee
Lesley A. Cottrell
Kelly Cowan
Viren A. D'Sa
Alexander G. Fiks
Maria L. Gennaro
Katherine Irby
Manaswitha Khare
Jeremy Landeo Guttierrez
Russell J. McCulloh
Shalu Narang
Manette Ness-Cochinwala
Sheila Nolan
Paul Palumbo
Julie Ryu
Juan C. Salazar
Rangaraj Selvarangan, Children's Mercy HospitalFollow
Cheryl R. Stein
Alan Werzberger
William T. Zempsky
Robin Aupperle
Fiona C. Baker
Marie T. Banich
Deanna M. Barch
Arielle Baskin-Sommers
James M. Bjork
Susan Y. Bookheimer
Sandra A. Brown
B J Casey
Linda Chang
Duncan B. Clark
Anders M. Dale
Mirella Dapretto
Thomas M. Ernst
Damien A. Fair
Sarah W. Feldstein Ewing
John J. Foxe
Edward G. Freedman
Naomi P. Friedman
Hugh Garavan
Dylan G. Gee
Raul Gonzalez
Kevin M. Gray
Mary M. Heitzeg
Megan M. Herting
Joanna Jacobus
Angela R. Laird
Christine L. Larson
Krista M. Lisdahl
Monica Luciana
Beatriz Luna
Pamela A F Madden
Erin C. McGlade
Eva M. Müller-Oehring
Bonnie J. Nagel
Michael C. Neale
Martin P. Paulus
Alexandra S. Potter
Perry F. Renshaw
Elizabeth R. Sowell
Lindsay M. Squeglia
Susan Tapert
Lucina Q. Uddin
Sylia Wilson
Deborah A. Yurgelun-Todd
Andrea S. Foulkes
Melissa S. Stockwell

Document Type

Article

Publication Date

10-2024

Identifier

DOI: 10.1001/jama.2024.12747; PMCID: PMC11339705

Abstract

IMPORTANCE: Most research to understand postacute sequelae of SARS-CoV-2 infection (PASC), or long COVID, has focused on adults, with less known about this complex condition in children. Research is needed to characterize pediatric PASC to enable studies of underlying mechanisms that will guide future treatment.

OBJECTIVE: To identify the most common prolonged symptoms experienced by children (aged 6 to 17 years) after SARS-CoV-2 infection, how these symptoms differ by age (school-age [6-11 years] vs adolescents [12-17 years]), how they cluster into distinct phenotypes, and what symptoms in combination could be used as an empirically derived index to assist researchers to study the likely presence of PASC.

DESIGN, SETTING, AND PARTICIPANTS: Multicenter longitudinal observational cohort study with participants recruited from more than 60 US health care and community settings between March 2022 and December 2023, including school-age children and adolescents with and without SARS-CoV-2 infection history.

EXPOSURE: SARS-CoV-2 infection.

MAIN OUTCOMES AND MEASURES: PASC and 89 prolonged symptoms across 9 symptom domains.

RESULTS: A total of 898 school-age children (751 with previous SARS-CoV-2 infection [referred to as infected] and 147 without [referred to as uninfected]; mean age, 8.6 years; 49% female; 11% were Black or African American, 34% were Hispanic, Latino, or Spanish, and 60% were White) and 4469 adolescents (3109 infected and 1360 uninfected; mean age, 14.8 years; 48% female; 13% were Black or African American, 21% were Hispanic, Latino, or Spanish, and 73% were White) were included. Median time between first infection and symptom survey was 506 days for school-age children and 556 days for adolescents. In models adjusted for sex and race and ethnicity, 14 symptoms in both school-age children and adolescents were more common in those with SARS-CoV-2 infection history compared with those without infection history, with 4 additional symptoms in school-age children only and 3 in adolescents only. These symptoms affected almost every organ system. Combinations of symptoms most associated with infection history were identified to form a PASC research index for each age group; these indices correlated with poorer overall health and quality of life. The index emphasizes neurocognitive, pain, and gastrointestinal symptoms in school-age children but change or loss in smell or taste, pain, and fatigue/malaise-related symptoms in adolescents. Clustering analyses identified 4 PASC symptom phenotypes in school-age children and 3 in adolescents.

CONCLUSIONS AND RELEVANCE: This study developed research indices for characterizing PASC in children and adolescents. Symptom patterns were similar but distinguishable between the 2 groups, highlighting the importance of characterizing PASC separately for these age ranges.

Journal Title

JAMA : the journal of the American Medical Association

Volume

332

Issue

14

First Page

1174

Last Page

1188

Library Record

Share

COinS